½ÃÀ庸°í¼­
»óǰÄÚµå
1342880

¼¼°èÀÇ ¸¶ÀÌÅ©·Î¹ÙÀÌ¿È »ùÇà Á¶Á¦ ±â¼ú ½ÃÀå Á¶»ç º¸°í¼­ : »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ, ¿¹Ãø(2023-2030³â)

Global Microbiome Sample Preparation Technology Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Value Market Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 221 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¸¶ÀÌÅ©·Î¹ÙÀÌ¿È »ùÇà Á¶Á¦ ±â¼ú ½ÃÀåÀÇ ¼¼°è ¼ö¿ä´Â 2023-2030³â Á¶»ç ±â°£ µ¿¾È 8.22%ÀÇ CAGR·Î 2022³â 2¾ï 7,822¸¸ ´Þ·¯¿¡¼­ 2030³â 5¾ï 2,342¸¸ ´Þ·¯¿¡ À°¹ÚÇÏ´Â ½ÃÀå ±Ô¸ð¿¡ À̸¦ °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù.

¸¶ÀÌÅ©·Î¹ÙÀÌ¿È »ùÇà Á¶Á¦ ±â¼úÀº ½ÃÄö½ÌÀ» À§ÇØ ¹Ì»ý¹° DNA¸¦ ºÐ¸®ÇÏ´Â µ¥ »ç¿ëµÇ¾î ¿Ô½À´Ï´Ù. ÀÌ ±â¼úÀº ¶ÇÇÑ ¹Ì»ý¹° Áý´Ü ¿¬±¸¿Í Àΰ£ Àå³» ¹Ì»ý¹° ±ºÁýÀÇ ºÐ·ùÇÐÀû ±¸¼º ºÐ¼®¿¡µµ »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. ÆÄŲ½¼º´À̳ª Å©·Ðº´°ú °°Àº Áúº´°ú °ü·ÃµÈ ¹Ì»ý¹°À» ½Äº°ÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù.

½ÃÀå ¿ªÇÐ:

ÀÓ»ó ¿¬±¸ °³¹ß¿¡¼­ ¸¶ÀÌÅ©·Î¹ÙÀÌ¿È ºÐ¼®ÀÇ Ã¤Å÷üµµ Áõ°¡ Ãß¼¼¿¡ ÀÖ¾î ÀÌ ±â¼ú¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÇöÀç ¶óÀÌÇÁ½ºÅ¸ÀÏÀÇ º¯È­¿Í °Ç°­¿¡ ÇØ·Î¿î ½Ä½À°üÀ¸·Î ÀÎÇØ ¸¸¼º Áúȯ ȯÀÚ°¡ Áõ°¡Çϰí ÀÖÀ¸¸ç, ÀÌ´Â ÇâÈÄ ¸î ³â µ¿¾È ¸¶ÀÌÅ©·Î¹ÙÀÌ¿È »ùÇà Á¶Á¦ ±â¼ú ½ÃÀåÀÇ ¼ºÀåÀ¸·Î À̾îÁú °ÍÀÔ´Ï´Ù. °³ÀÎ ¸ÂÃãÇü ÇコÄɾ ´ëÇÑ ¼ö¿ä Áõ°¡µµ ÀÌ ½ÃÀåÀÇ ¼ºÀåÀ» µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù. ÀÌ ¿Ü¿¡µµ ÇÁ·Î¹ÙÀÌ¿Àƽ½ºÀÇ °Ç°­ È¿°ú¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö°í Ä¡·áÁ¦·Î¼­ Ç×»ýÁ¦ »ç¿ë·®ÀÌ Áõ°¡Çϸ鼭 ¸¶ÀÌÅ©·Î¹ÙÀÌ¿È »ùÇà Á¶Á¦ ±â¼ú »ê¾÷ÀÇ ¼öÀÍÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ±×·¯³ª ½ÅÈï °æÁ¦±¹¿¡¼­´Â ÀÚ°ÝÀ» °®Ãá ¹Ì»ý¹°ÇÐÀÚ°¡ ºÎÁ·Çϱ⠶§¹®¿¡ ¼ºÀå¿¡ ¾à°£ÀÇ Á¦µ¿ÀÌ °É¸± °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Á¶»ç º¸°í¼­´Â Porter's Five Forces ¸ðµ¨, ½ÃÀå ¸Å·Âµµ ºÐ¼®, ¹ë·ùüÀÎ ºÐ¼®À» ´Ù·ç°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ µµ±¸´Â ¾÷°èÀÇ ±¸Á¶¸¦ ¸íÈ®ÇÏ°Ô ÆÄ¾ÇÇÏ°í ¼¼°è ¼öÁØ¿¡¼­ °æÀïÀÇ ¸Å·ÂÀ» Æò°¡ÇÏ´Â µ¥ µµ¿òÀ̵˴ϴÙ. ¶ÇÇÑ ÀÌ·¯ÇÑ µµ±¸´Â ¸¶ÀÌÅ©·Î¹ÙÀÌ¿È »ùÇà Á¶Á¦ ±â¼ú ¼¼°è ½ÃÀå¿¡¼­ °¢ ºÎ¹®À» Æ÷°ýÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ¸¶ÀÌÅ©·Î¹ÙÀÌ¿È »ùÇà Á¶Á¦ ±â¼ú »ê¾÷ÀÇ ¼ºÀå°ú µ¿ÇâÀº ÀÌ ¿¬±¸¿¡ ´ëÇÑ ÀüüÀûÀÎ Á¢±Ù ¹æ½ÄÀ» Á¦°øÇÕ´Ï´Ù.

Áö¿ªº° ºÐ¼®:

ÀÌ ¼½¼Ç¿¡¼­´Â ºÏ¹Ì, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ¸¶ÀÌÅ©·Î¹ÙÀÌ¿È »ùÇà Á¶Á¦ ±â¼ú ½ÃÀåÀÇ ÇöÀç ¹× ¹Ì·¡ ¼ö¿ä¸¦ °­Á¶ÇÏ´Â Áö¿ª Àü¸ÁÀ» ´Ù·ì´Ï´Ù. ¶ÇÇÑ, ÀÌ º¸°í¼­´Â ¸ðµç ÁÖ¿ä Áö¿ªÀÇ °³º° ¾ÖÇø®ÄÉÀÌ¼Ç ºÎ¹®ÀÇ ¼ö¿ä, ÃßÁ¤ ¹× ¿¹Ãø¿¡ ÃÊÁ¡À» ¸ÂÃß°í ÀÖ½À´Ï´Ù.

¿äûÀÌ ÀÖÀ¸½Ã¸é ÀúÈñ¿¡°Ô ¿¬¶ô Áֽñ⠹ٶø´Ï´Ù. ÀúÈñ Á¶»çÆÀÀº °í°´ÀÇ ¿ä±¸¿¡ µû¶ó ¸ÂÃãÇü º¸°í¼­¸¦ Á¦°øÇÒ ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå ÁÖ¿ä ¿ä¾à

  • ½ÃÀå ÇÏÀ̶óÀÌÆ®
  • ¼¼°è ½ÃÀå ÇöȲ

Á¦3Àå ¸¶ÀÌÅ©·Î¹ÙÀÌ¿È »ùÇà Á¶Á¦ ±â¼ú - »ê¾÷ ºÐ¼®

  • ¼­·Ð : ½ÃÀå ¿ªÇÐ
  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
  • ½ÃÀå ±âȸ
  • ¾÷°è µ¿Çâ
  • Porter's Five Forces ºÐ¼®
  • ½ÃÀå ¸Å·Âµµ ºÐ¼®

Á¦4Àå ¹ë·ùüÀÎ ºÐ¼®

  • ¹ë·ùüÀÎ ºÐ¼®
  • ¿øÀç·á ºÐ¼®
    • ¿øÀç·á ¸®½ºÆ®
    • ¿øÀç·á Á¦Á¶¾÷ü ¸®½ºÆ®
    • ÁÖ¿ä ¿øÀç·á °¡°Ý µ¿Çâ
  • ÀáÀçÀû ¹ÙÀÌ¾î ¸®½ºÆ®
  • ¸¶ÄÉÆÃ Ã¤³Î
    • Á÷Á¢ ¸¶ÄÉÆÃ
    • °£Á¢ ¸¶ÄÉÆÃ
    • ¸¶ÄÉÆÃ Ã¤³Î ¹ßÀü µ¿Çâ

Á¦5Àå COVID-19 ¹ß»ýÀÇ ¿µÇ⠺м®

  • COVID-19 ¹ß»ýÀÇ ¿µÇ⠺м®
    • »ý»ê¿¡ ´ëÇÑ Á÷Á¢Àû ¿µÇâ
    • °ø±Þ¸Á°ú ½ÃÀå È¥¶õ
    • ±â¾÷ ¹× ±ÝÀ¶ ½ÃÀå¿¡ ´ëÇÑ À繫Àû ¿µÇâ
  • COVID-19ÀÇ »ý»ê, ¼öÀÔ, ¼öÃâ, ¼ö¿ä¿¡ ÀÇÇÑ ¿µÇ⠺м®
  • ½ÃÀå COVID-19 ÀÌÀü/ÀÌÈÄ
  • Äڷγª¹ÙÀÌ·¯½º(COVID-19) À¯ÇàÀÇ ¿µÇâ ¿¹Ãø
  • COVID-19 : ¹Ì½ÃÀû ¹× °Å½ÃÀû ¿äÀÎ ºÐ¼®

Á¦6Àå ¸¶ÀÌÅ©·Î¹ÙÀÌ¿È »ùÇà Á¶Á¦ ±â¼ú ¼¼°è ½ÃÀå ºÐ¼® : Á¦Ç°º°

  • Á¦Ç°º° °³¿ä
  • ½ÇÀû µ¥ÀÌÅÍ¿Í ¿¹Ãø µ¥ÀÌÅÍ
  • Á¦Ç°º° ºÐ¼®
  • ±â±¸
  • ¼Ò¸ðǰ

Á¦7Àå ¸¶ÀÌÅ©·Î¹ÙÀÌ¿È »ùÇà Á¶Á¦ ±â¼ú ¼¼°è ½ÃÀå ºÐ¼® : ¿öÅ©Ç÷ο캰

  • ¿öÅ©Ç÷ο캰 °³¿ä
  • ½ÇÀû µ¥ÀÌÅÍ¿Í ¿¹Ãø µ¥ÀÌÅÍ
  • ¿öÅ©Ç÷ο캰 ºÐ¼®
  • »ùÇà ÃßÃâ/´Ü¸®
  • »ùÇà Á¤·®
  • ǰÁú °ü¸®
  • ´ÜÆíÈ­
  • ¶óÀ̺귯¸® Á¶Á¦
  • Ÿ°Ù ³óÃà
  • ¶óÀ̺귯¸® Á¤·®
  • Ç®¸µ

Á¦8Àå ¸¶ÀÌÅ©·Î¹ÙÀÌ¿È »ùÇà Á¶Á¦ ±â¼ú ¼¼°è ½ÃÀå ºÐ¼® : ¿ëµµº°

  • °³¿ä : ¿ëµµº°
  • ½ÇÀû µ¥ÀÌÅÍ¿Í ¿¹Ãø µ¥ÀÌÅÍ
  • ºÐ¼® : ¿ëµµº°
  • DNA ½ÃÄö½Ì
  • Àü°Ô³ð ½ÃÄö½Ì
  • RNA ½ÃÄö½Ì
  • ¸Þƿȭ ½ÃÄö½Ì
  • ¸ÞŸÀ¯ÀüüÇÐ
  • ´ÜÀϼ¼Æ÷ ½ÃÄö½Ì
  • ±âŸ

Á¦9Àå ¸¶ÀÌÅ©·Î¹ÙÀÌ¿È »ùÇà Á¶Á¦ ±â¼ú ¼¼°è ½ÃÀå ºÐ¼® : Áúȯº°

  • Áúȯº° °³¿ä
  • ½ÇÀû µ¥ÀÌÅÍ¿Í ¿¹Ãø µ¥ÀÌÅÍ
  • Áúȯº° ºÐ¼®
  • ÀÚ°¡¸é¿ªÁúȯ
  • ¾Ï
  • ¼ÒÈ­±âÁúȯ
  • ±âŸ

Á¦10Àå ¸¶ÀÌÅ©·Î¹ÙÀÌ¿È »ùÇà Á¶Á¦ ±â¼ú ¼¼°è ½ÃÀå ºÐ¼® : ÃÖÁ¾ ¿ëµµº°

  • ÃÖÁ¾ ¿ëµµº° °³¿ä
  • ½ÇÀû µ¥ÀÌÅÍ¿Í ¿¹Ãø µ¥ÀÌÅÍ
  • ÃÖÁ¾ ¿ëµµº° ºÐ¼®
  • Á¦¾à¡¤¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö
  • Áø´Ü ½ÇÇè½Ç
  • ±âŸ

Á¦11Àå ¸¶ÀÌÅ©·Î¹ÙÀÌ¿È »ùÇà Á¶Á¦ ±â¼ú ¼¼°è ½ÃÀå ºÐ¼® : Áö¿ªº°

  • »óÀ§ ±â¾÷ Á¡À¯À² ºÐ¼®
  • ¼­·Ð
  • ºÏ¹Ì ¸ÅÃ⠺м®
    • °³¿ä, ½ÇÀû°ú ¿¹Ãø
    • ºÏ¹Ì ºÎ¹®º°
    • ºÏ¹Ì : ±¹°¡º°
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´ ¸ÅÃ⠺м®
    • °³¿ä, ½ÇÀû°ú ¿¹Ãø
    • À¯·´ : ºÎ¹®º°
    • À¯·´ : ±¹°¡º°
    • ¿µ±¹
    • ÇÁ¶û½º
    • µ¶ÀÏ
    • ÀÌÅ»¸®¾Æ
    • ·¯½Ã¾Æ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç ¸ÅÃ⠺м®
    • °³¿ä, ½ÇÀû°ú ¿¹Ãø
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : ºÎ¹®º°
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : ±¹°¡º°
    • Áß±¹
    • Àεµ
    • ÀϺ»
    • Çѱ¹
    • È£ÁÖ
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä« ¸ÅÃ⠺м®
    • °³¿ä, ½ÇÀû°ú ¿¹Ãø
    • ¶óƾ¾Æ¸Þ¸®Ä« : ºÎ¹®º°
    • ¶óƾ¾Æ¸Þ¸®Ä« : ±¹°¡º°
    • ºê¶óÁú
    • ¾Æ¸£ÇîÆ¼³ª
    • Æä·ç
    • Ä¥·¹
    • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« ¸ÅÃ⠺м®
    • °³¿ä, ½ÇÀû°ú ¿¹Ãø
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ºÎ¹®º°
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ±¹°¡º°
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®
    • À̽º¶ó¿¤
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦12Àå ¸¶ÀÌÅ©·Î¹ÙÀÌ¿È »ùÇà Á¶Á¦ ±â¼ú ±â¾÷ °æÀï »óȲ

  • ¸¶ÀÌÅ©·Î¹ÙÀÌ¿È »ùÇà Á¶Á¦ ±â¼ú ½ÃÀå °æÀï
  • ÆÄÆ®³Ê½Ê/Á¦ÈÞ/ÇÕÀÇ
  • ÀμöÇÕº´
  • ½ÅÁ¦Ç° Ãâ½Ã
  • ±âŸ °³¹ß

Á¦13Àå ±â¾÷ °³¿ä

  • ±â¾÷ Á¡À¯À² ºÐ¼®
  • ½ÃÀå ÁýÁßµµ
  • QIAGEN
  • BGI
  • Bio-Rad Laboratories Inc.
  • Perkin Elmer Inc.
  • Agilent Technologies Inc.
  • Illumina Inc.
  • F. Hoffmann-La Roche Ltd.
  • Danaher Corporation
ksm 23.10.13

The global demand for Microbiome Sample Preparation Technology Market is presumed to reach the market size of nearly USD 523.42 MN by 2030 from USD 278.22 MN in 2022 with a CAGR of 8.22% under the study period 2023 - 2030.

Microbiome sample preparation technology has been used to isolate microbial DNA for sequencing. This technique has also been used for microbial population studies and to analyze the taxonomic composition of bacterial populations in human gut microbiomes. It helps to identify microbes that are associated with diseases such as Parkinson's disease and Crohn's disease.

MARKET DYNAMICS:

The adoption rate of microbiome analysis in clinical research and development is also on the rise leading to more demand for this technology. Chronic disease cases are currently rising due to lifestyle changes and unhealthy food habits, leading to the growth of the microbiome sample preparation technology market in the coming years. There has been an increase in demand for personalized healthcare, which is also supporting the growth of this market. Other drivers, such as increased awareness about the health benefits of probiotics and the rising use of antibiotics as treatment, is pushing the microbiome sample preparation technology industry revenue uphill. However, the growth can foresee some hiccups due to the lack of qualified microbiologists in developing economies.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of microbiome sample preparation technology. The growth and trends of microbiome sample preparation technology industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the microbiome sample preparation technology market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

  • Instruments
  • Consumables

By Workflow

  • Sample Extraction/Isolation
  • Sample Quantification
  • Quality Control
  • Fragmentation
  • Library Preparation
  • Target Enrichment
  • Library Quantification
  • Pooling

By Application

  • DNA Sequencing
  • Whole-Genome Sequencing
  • RNA Sequencing
  • Methylation Sequencing
  • Metagenomics
  • Single Cell Sequencing
  • Others

By Disease

  • Autoimmune Disorder
  • Cancer
  • Gastrointestinal Disorders
  • Others

By End-Use

  • Pharmaceutical & Biotechnology
  • Diagnostic Labs
  • Others

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Microbiome Sample Preparation Technology market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the microbiome sample preparation technology market include QIAGEN, BGI, Bio-Rad Laboratories Inc., Perkin Elmer Inc., Agilent Technologies Inc., Illumina Inc., F. Hoffmann-La Roche Ltd., Danaher Corporation. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . MICROBIOME SAMPLE PREPARATION TECHNOLOGY - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product
    • 3.7.2 Market Attractiveness Analysis By Workflow
    • 3.7.3 Market Attractiveness Analysis By Application
    • 3.7.4 Market Attractiveness Analysis By Disease
    • 3.7.5 Market Attractiveness Analysis By End-use
    • 3.7.6 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5. IMPACT ANALYSIS OF COVID-19 OUTBREAK

  • 5.1. Impact Analysis of Covid-19 Outbreak
    • 5.1.1. Direct Impact on Production
    • 5.1.2. Supply Chain and Market Disruption
    • 5.1.3. Financial Impact on Firms and Financial Markets
  • 5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
  • 5.3. Market: Pre V/S Post COVID-19
  • 5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic
  • 5.5. COVID-19: Micro and Macro Factor Analysis

6 . GLOBAL MICROBIOME SAMPLE PREPARATION TECHNOLOGY MARKET ANALYSIS BY PRODUCT

  • 6.1 Overview by Product
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Product
  • 6.4 Instruments Historic and Forecast Sales by Regions
  • 6.5 Consumables Historic and Forecast Sales by Regions

7 . GLOBAL MICROBIOME SAMPLE PREPARATION TECHNOLOGY MARKET ANALYSIS BY WORKFLOW

  • 7.1 Overview by Workflow
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Workflow
  • 7.4 Sample Extraction/Isolation Historic and Forecast Sales by Regions
  • 7.5 Sample Quantification Historic and Forecast Sales by Regions
  • 7.6 Quality Control Historic and Forecast Sales by Regions
  • 7.7 Fragmentation Historic and Forecast Sales by Regions
  • 7.8 Library Preparation Historic and Forecast Sales by Regions
  • 7.9 Target Enrichment Historic and Forecast Sales by Regions
  • 7.10. Library Quantification Historic and Forecast Sales by Regions
  • 7.11 Pooling Historic and Forecast Sales by Regions

8 . GLOBAL MICROBIOME SAMPLE PREPARATION TECHNOLOGY MARKET ANALYSIS BY APPLICATION

  • 8.1 Overview by Application
  • 8.2 Historical and Forecast Data
  • 8.3 Analysis by Application
  • 8.4 DNA Sequencing Historic and Forecast Sales by Regions
  • 8.5 Whole-Genome Sequencing Historic and Forecast Sales by Regions
  • 8.6 RNA Sequencing Historic and Forecast Sales by Regions
  • 8.7 Methylation Sequencing Historic and Forecast Sales by Regions
  • 8.8 Metagenomics Historic and Forecast Sales by Regions
  • 8.9 Single Cell Sequencing Historic and Forecast Sales by Regions
  • 8.10. Others Historic and Forecast Sales by Regions

9 . GLOBAL MICROBIOME SAMPLE PREPARATION TECHNOLOGY MARKET ANALYSIS BY DISEASE

  • 9.1 Overview by Disease
  • 9.2 Historical and Forecast Data
  • 9.3 Analysis by Disease
  • 9.4 Autoimmune Disorder Historic and Forecast Sales by Regions
  • 9.5 Cancer Historic and Forecast Sales by Regions
  • 9.6 Gastrointestinal Disorders Historic and Forecast Sales by Regions
  • 9.7 Others Historic and Forecast Sales by Regions

10 . GLOBAL MICROBIOME SAMPLE PREPARATION TECHNOLOGY MARKET ANALYSIS BY END-USE

  • 10.1 Overview by End-use
  • 10.2 Historical and Forecast Data
  • 10.3 Analysis by End-use
  • 10.4 Pharmaceutical & Biotechnology Historic and Forecast Sales by Regions
  • 10.5 Diagnostic Labs Historic and Forecast Sales by Regions
  • 10.6 Others Historic and Forecast Sales by Regions

11 . GLOBAL MICROBIOME SAMPLE PREPARATION TECHNOLOGY MARKET ANALYSIS BY GEOGRAPHY

  • 11.1. Top Company Share Analysis
  • 11.2. Introduction
  • 11.3. North America Sales Analysis
    • 11.3.1. Overview, Historic and Forecast Sales Analysis
    • 11.3.2. North America By Segment Sales Analysis
    • 11.3.3. North America By Country Sales Analysis
    • 11.3.4. United State Sales Analysis
    • 11.3.5. Canada Sales Analysis
    • 11.3.6. Mexico Sales Analysis
  • 11.4. Europe Sales Analysis
    • 11.4.1. Overview, Historic and Forecast Sales Analysis
    • 11.4.2. Europe by Segment Sales Analysis
    • 11.4.3. Europe by Country Sales Analysis
    • 11.4.4. United Kingdom Sales Analysis
    • 11.4.5. France Sales Analysis
    • 11.4.6. Germany Sales Analysis
    • 11.4.7. Italy Sales Analysis
    • 11.4.8. Russia Sales Analysis
    • 11.4.9. Rest Of Europe Sales Analysis
  • 11.5. Asia Pacific Sales Analysis
    • 11.5.1. Overview, Historic and Forecast Sales Analysis
    • 11.5.2. Asia Pacific by Segment Sales Analysis
    • 11.5.3. Asia Pacific by Country Sales Analysis
    • 11.5.4. China Sales Analysis
    • 11.5.5. India Sales Analysis
    • 11.5.6. Japan Sales Analysis
    • 11.5.7. South Korea Sales Analysis
    • 11.5.8. Australia Sales Analysis
    • 11.5.9. Rest Of Asia Pacific Sales Analysis
  • 11.6. Latin America Sales Analysis
    • 11.6.1. Overview, Historic and Forecast Sales Analysis
    • 11.6.2. Latin America by Segment Sales Analysis
    • 11.6.3. Latin America by Country Sales Analysis
    • 11.6.4. Brazil Sales Analysis
    • 11.6.5. Argentina Sales Analysis
    • 11.6.6. Peru Sales Analysis
    • 11.6.7. Chile Sales Analysis
    • 11.6.8. Rest of Latin America Sales Analysis
  • 11.7. Middle East & Africa Sales Analysis
    • 11.7.1. Overview, Historic and Forecast Sales Analysis
    • 11.7.2. Middle East & Africa by Segment Sales Analysis
    • 11.7.3. Middle East & Africa by Country Sales Analysis
    • 11.7.4. Saudi Arabia Sales Analysis
    • 11.7.5. UAE Sales Analysis
    • 11.7.6. Israel Sales Analysis
    • 11.7.7. South Africa Sales Analysis
    • 11.7.8. Rest Of Middle East And Africa Sales Analysis

12 . COMPETITIVE LANDSCAPE OF THE MICROBIOME SAMPLE PREPARATION TECHNOLOGY COMPANIES

  • 12.1. Microbiome Sample Preparation Technology Market Competition
  • 12.2. Partnership/Collaboration/Agreement
  • 12.3. Merger And Acquisitions
  • 12.4. New Product Launch
  • 12.5. Other Developments

13 . COMPANY PROFILES OF MICROBIOME SAMPLE PREPARATION TECHNOLOGY INDUSTRY

  • 13.1. Company Share Analysis
  • 13.2. Market Concentration Rate
  • 13.3. QIAGEN
    • 13.3.1. Company Overview
    • 13.3.2. Company Revenue
    • 13.3.3. Products
    • 13.3.4. Recent Developments
  • 13.4. BGI
    • 13.4.1. Company Overview
    • 13.4.2. Company Revenue
    • 13.4.3. Products
    • 13.4.4. Recent Developments
  • 13.5. Bio-Rad Laboratories Inc.
    • 13.5.1. Company Overview
    • 13.5.2. Company Revenue
    • 13.5.3. Products
    • 13.5.4. Recent Developments
  • 13.6. Perkin Elmer Inc.
    • 13.6.1. Company Overview
    • 13.6.2. Company Revenue
    • 13.6.3. Products
    • 13.6.4. Recent Developments
  • 13.7. Agilent Technologies Inc.
    • 13.7.1. Company Overview
    • 13.7.2. Company Revenue
    • 13.7.3. Products
    • 13.7.4. Recent Developments
  • 13.8. Illumina Inc.
    • 13.8.1. Company Overview
    • 13.8.2. Company Revenue
    • 13.8.3. Products
    • 13.8.4. Recent Developments
  • 13.9. F. Hoffmann-La Roche Ltd.
    • 13.9.1. Company Overview
    • 13.9.2. Company Revenue
    • 13.9.3. Products
    • 13.9.4. Recent Developments
  • 13.10. Danaher Corporation
    • 13.10.1. Company Overview
    • 13.10.2. Company Revenue
    • 13.10.3. Products
    • 13.10.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦